Log in

Introduction of miR-3613-3p as a regulator of transforming growth factor-β (TGF-β) signaling pathway in colorectal cancer

  • Original Article
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Introduction

Colorectal cancer (CRC) is the second common cancer and the fourth major reason of cancer death worldwide. Dysregulation of intracellular pathways, such as TGF-β/SMAD signaling, contributes to CRC development. MicroRNAs (miRNAs) are post-transcriptional regulators that are involved in CRC pathogenesis. Here, we aimed to investigate the effect of miR-3613-3p on the TGF-β /SMAD signaling pathway in CRC.

Methods & results

Bioinformatics analysis suggested that miR-3613-3p is a regulator of TGF-Β signaling downstream genes. Then, miR-3613-3p overexpression was followed by downregulation of TGF-βR1, TGF-βR2, and SMAD2 expression levels, detected by RT-qPCR. Additionally, dual luciferase assay supported the direct interaction of miR-3613-3p with 3’UTR sequences of TGF-βR1 and TGF-βR2 genes. Furthermore, reduced SMAD3 protein level following the miR-3613-3p overexpression verified its suppressive effect against TGF-β signaling in HCT-116 cells, detected by western blot analysis. Finally, miR-3613-3p overexpression induced sub-G1 arrest in HCT116 cells, detected by flow cytometry, and promoted downregulation of cyclin D1 protein expression, which was detected by western blotting analysis.

Conclusion

Our findings indicated that miR-3613-3p plays an important role in CRC by targeting the TGF-β/SMAD signaling pathway and could be considered as a new candidate for further therapy investigations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

All of the related data including originals of the experiments will be available upon request.

Abbreviations

CRC:

Colorectal cancer

WNT:

Wingless/Integrated

MAPK:

Mitogen-Activated Protein Kinase

TGF-β:

Transforming Growth Factor Beta

TGF-βR:

Transforming Growth Factor Beta Receptor

SMAD:

Small mothers against decapentaplegic

R-SMAD:

Receptor-regulated Smad

CO-SMAD:

Common mediator Smad

SMAD6/7:

Inhibitory Smad 6/7

miRNAs:

MicroRNAs

MREs:

miRNA recognition elements

3’UTR:

3’ Untranslated Region

References

  1. Siegel R, Sandeep Wagle N, Cercek A, Smith R, Jemal A (2023) Colorectal cancer statistics,CA. Cancer J Clin 73:233–254

    Article  Google Scholar 

  2. Cao Z (2015) N.J.A.j.o.u. Kyprianou, mechanisms navigating the TGF-β pathway in prostate cancer. 2(1):11–18

  3. Nature C (2012) Comprehensive molecular characterization of human colon and rectal cancer. 487(7407):330

  4. Pellatt AJ et al (2018) The TGF-Β-signaling pathway and colorectal cancer: associations between dysregulated genes and miRNAs. 16(1):191

  5. Dandan Peng (2022) Targeting TGF-β signal transduction for fibrosis and cancer therapy. Mole Cancer 21(1):104

    Article  Google Scholar 

  6. Ringuette Goulet, C., and Pouliot, F. TGF-Β signaling in the Tumor Microenvironment. Adv Exp Med Biol. (2021) :1270:89–105

    Article  CAS  PubMed  Google Scholar 

  7. Eulalio A, Huntzinger E, Izaurralde EJC (2008) Getting to the root of miRNA. -mediated gene Silencing 132(1):9–14

    CAS  Google Scholar 

  8. Chekulaeva M (2009) W.J.C.o.i.c.b. Filipowicz, mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. 21(3):452–460

  9. Pereira DM et al (2013) Delivering Promise miRNA cancer Ther 18(5–6):282–289

    CAS  Google Scholar 

  10. Svoronos AA, Engelman DM (2016) J.J.C.r. Slack, OncomiR or tumor suppressor? The duplicity of microRNAs in cancer. 76(13):3666–3670

  11. Rustam Effendi-Ys., Colonoscopy, Biomarkers, and Targeted Therapy in Colorectal Cancer Acta Med Indones, (2022) Jul;54(3):476–486

  12. Tanksley JP (2013) Tales of Three Signaling pathways: EGFR, TGF-Β, and WNT signaling in the GI Tract. Vanderbilt University

  13. Iordanskaia T, Nawshad A (2011) Mechanisms of transforming growth factor β induced cell cycle arrest in palate development. J Cell Physiol 226(5):1415–1424

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Huang X et al Dissecting miRNA signature in colorectal cancer progression and metastasis Cancer Lett., 2021. Mar 31;501:66–82

  15. - Sheng K, Pong M, Gullerova (2018) Noncanonical functions of microRNA pathway enzymes - Drosha, DGCR8, Dicer and Ago proteins. FEBS Lett., Sep;592(17):2973–2986

  16. Rusk N (2008) When microRNAs activate translation. Nat Methods 5(2):122

    Article  CAS  Google Scholar 

  17. Sebastian-delaCruz M et al (2021) The role of lncRNAs in gene expression regulation through mRNA stabilization. Non-coding RNA 7(1):3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. **ao B et al (2012) Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis. Oncol Rep 27(2):559–566

    CAS  PubMed  Google Scholar 

  19. Jahangirimoez M et al (2020) Hsa-miR-587 regulates TGF-Β/SMAD signaling and promotes cell cycle progression. Cell J (Yakhteh) 22(2):158

    Google Scholar 

  20. Jafarzadeh M, Soltani BM (2016) Hsa-Mir-590-5p Interaction with SMAD3 transcript supports its Regulatory Effect on the TGF-Β signaling pathway. Cell J (Yakhteh) 18(1):7

    Google Scholar 

  21. Abedini Bakhshmand E et al (2018) Hsa-miR‐5582‐3P regulatory effect on TGF-Β signaling through targeting of TGF-Β‐R1, TGF-Β‐R2, SMAD3, and SMAD4 transcripts. J Cell Biochem 119(12):9921–9930

    Article  CAS  PubMed  Google Scholar 

  22. Dokanehiifard S, Soltani BM (2019) TrkC-miR2 regulates TGF-Β signaling pathway through targeting of SMAD3 transcript. J Cell Biochem 120(2):2634–2641

    Article  CAS  PubMed  Google Scholar 

  23. Mori Y, Chen S-J, Varga J (2000) Modulation of endogenous smad expression in normal skin fibroblasts by transforming growth factor-β. Exp Cell Res 258(2):374–383

    Article  CAS  PubMed  Google Scholar 

  24. Wu W, Wang X, Yu X, Lan HY Smad3 signatures in renal inflammation and fibrosis. Int J Biol Sci 2022 Mar 28;18(7):2795–2806

  25. Gordan JD, Thompson CB, Simon MC (2007) HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell 12(2):108–113

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Zhang K et al (2020) The dichotomous role of TGF-β in controlling liver cancer cell survival and proliferation. J Genet Genomics 47(9):497–512

    Article  CAS  PubMed  Google Scholar 

  27. Chen C, Pan Y, Bai L, Chen H, Duan Z, Si Q, Zhu R, Chuang T, Luo Y MicroRNA-3613-3p functions as a tumor suppressor and represents a novel therapeutic target in breast cancer. Breast Cancer Res. 2021 Jan 25;23(1):12

  28. Hu Y, He J, He L, Xu B, Wang QJ (2021) Expression and function of Smad7 in autoimmune and inflammatory diseases. Mol Med (Berl) 99(9):1209–1220

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank 4402 Lab mates for their cooperation’s.

Funding

This work was supported by Tarbiat Modares University, National Science Foundation (INSF# 96012116) financial aids.

Author information

Authors and Affiliations

Authors

Contributions

MJ & TH; performed the experiments, TH & PB; Helped the experiments BMS; designed and supervised the experiments, MB; advised the research.

Corresponding author

Correspondence to Bahram M. Soltani.

Ethics declarations

Conflict of interest

The authors declare that there are no conflicts of interest with any financial organization regarding the material discussed in the manuscript. Also, none of the authors have any non-financial conflict of interest.

Ethical approval

This study was carried out in accordance with the recommendations of the Research Ethics Committee of Tarbiat Modares University. All subjects gave written informed consent in accordance with the Declaration of Helsinki. Permission from the responsible authorities was granted. (Ethical code: IR.MODARES.REC.1400.136)

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jafarian, M., Hasannia, T., Badameh, P. et al. Introduction of miR-3613-3p as a regulator of transforming growth factor-β (TGF-β) signaling pathway in colorectal cancer. Mol Biol Rep 51, 728 (2024). https://doi.org/10.1007/s11033-024-09419-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11033-024-09419-3

Keywords

Navigation